TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT00693342

Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“Never opened to accrual, a GOG working number, not developed into a clinical trial.”

The sponsor’s own words in the registry.

Life of this trial

2008201020122014201620182020Registered2008-06-06Withdrawn (as of)2020-02-24

Vital statistics

Status
Withdrawn
Phase
Phase 3
Sponsor
Gynecologic Oncology Group
Sponsor type
University, hospital or other
Conditions
Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions
immunological adjuvant OPT-821; polyvalent antigen-KLH conjugate vaccine
Participants
0

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.